高血压精准医学:药物基因组学的承诺和陷
Nhu Ngoc Le1, Iain Frater1, Stefanie Lip1
1School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, UK.
Pharmacogenomics
|May 27, 2025
概括
药物基因组学 (PGx) 通过分析遗传特征,提供个性化的高血压治疗. 然而,遗传复杂性和实施障碍等挑战限制了其广泛的临床使用.
科学领域:
- 心血管医学 心血管医学
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 通过根据个体遗传特征量身定制治疗方法,可以改善高血压的管理.
- 药物基因组学 (PGx) 是个性化抗高血压疗法的前景.
- 由于遗传复杂性和实施障碍,PGx在高血压的临床应用面临挑战.
研究的目的:
- 审查高血压的遗传基础和影响药物反应的关键药物遗传学标记.
- 探索PGx在个性化高血压治疗和克服当前局限性的潜力.
- 讨论高血压护理中PGx的新兴技术和未来研究方向.
主要方法:
- 对影响抗高血压药物代谢和疗效的遗传标志物 (例如,CYP2D6,CYP3A4,UMOD,ACE) 的审查.
- 检查孟德尔随机化和多基因风险评分,用于药物开发和治疗反应分层.
- 对实施障碍的分析,包括临床可行性,试验数据,成本和公平性.
主要成果:
- 确定了影响高血压药物疗效和新陈代谢的关键遗传多态.
- 突出了PGx在减少试错处方和改善遵守方面的潜力.
- 认可了PGx广泛采用的重大障碍,包括成本和缺乏大型试验.
结论:
- 药物基因组学为精确高血压管理提供了一个有希望的途径.
- 克服实施障碍和进行进一步的临床验证对于例行采用至关重要.
- 新兴技术可能会提高PGx精度,但要将其整合到临床实践中,需要政策和研究.
相关概念视频
Errors occurring during blood pressure monitoring
984
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
984
Hypertension II: Pathophysiology
91
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
91
Hypertension III: Clinical Manifestations and Diagnostic Studies
60
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
60
Hypertension I: Introduction
89
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
89
Hypertension and Regulation of Blood Pressure
3.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


